Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 19% ± 3% | |
| glutamatergic neuron | 4 studies | 25% ± 9% | |
| endothelial cell | 3 studies | 18% ± 2% | |
| oligodendrocyte precursor cell | 3 studies | 19% ± 1% | |
| neuron | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 953.07 | 2640 / 2642 | 100% | 23.35 | 705 / 705 |
| breast | 100% | 891.06 | 459 / 459 | 100% | 26.41 | 1116 / 1118 |
| prostate | 100% | 1028.78 | 245 / 245 | 100% | 17.50 | 501 / 502 |
| ovary | 100% | 1143.41 | 180 / 180 | 100% | 19.51 | 428 / 430 |
| uterus | 100% | 1145.62 | 170 / 170 | 99% | 16.83 | 456 / 459 |
| thymus | 100% | 1150.03 | 653 / 653 | 99% | 15.80 | 600 / 605 |
| lung | 100% | 784.44 | 577 / 578 | 99% | 16.65 | 1141 / 1155 |
| kidney | 100% | 916.73 | 89 / 89 | 98% | 13.29 | 887 / 901 |
| bladder | 100% | 895.38 | 21 / 21 | 98% | 14.96 | 495 / 504 |
| adrenal gland | 100% | 1026.88 | 258 / 258 | 98% | 11.20 | 225 / 230 |
| esophagus | 100% | 839.46 | 1445 / 1445 | 97% | 16.57 | 178 / 183 |
| pancreas | 99% | 435.36 | 324 / 328 | 98% | 12.16 | 175 / 178 |
| stomach | 100% | 621.47 | 359 / 359 | 95% | 12.31 | 271 / 286 |
| intestine | 100% | 845.76 | 966 / 966 | 95% | 10.72 | 499 / 527 |
| skin | 100% | 979.15 | 1808 / 1809 | 90% | 11.76 | 423 / 472 |
| liver | 100% | 448.61 | 226 / 226 | 87% | 7.36 | 355 / 406 |
| adipose | 100% | 806.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 724.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 850.51 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 13.61 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.18 | 1 / 1 |
| heart | 99% | 621.61 | 855 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 8.72 | 28 / 29 |
| muscle | 96% | 333.16 | 767 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 60% | 4.08 | 48 / 80 |
| peripheral blood | 40% | 363.24 | 371 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF260 |
| Protein name | Zinc finger protein 260 (Zfp-260) Alternative protein ZNF260 |
| Synonyms | ZFP260 |
| Description | FUNCTION: Transcription factor that acts as a cardiac regulator and an effector of alpha1-adrenergic signaling. Binds to PE response elements (PERE) present in the promoter of genes such as ANF/NPPA and acts as a direct transcriptional activator of NPPA. Also acts as a cofactor with GATA4, a key cardiac regulator (By similarity). . |
| Accessions | ENST00000592282.1 ENST00000593142.5 Q3ZCT1 ENST00000588993.1 ENST00000523638.6 L8E9K3 |
